Actinium Pharmaceuticals, Inc. (ATNM) News https://ir.actiniumpharma.com/annual-reports/rss Actinium Pharmaceuticals, Inc. (ATNM) - Annual Reports en-us Equisolve Investor Relations Suite https://d1io3yog0oux5.cloudfront.net/_29d8dc0daa7a33e582da454b16a2dac9/actiniumpharma/files/images/logo.png https://www.actiniumpharma.com <![CDATA[ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] ]]> 10-K, EX-21.1, EX-23.1, EX-23.2, EX-31.1, EX-32.1 ]]> https://ir.actiniumpharma.com/annual-reports?page=1#document-3331-0001213900-26-036504 Mon, 30 Mar 26 17:45:59 -0400 https://ir.actiniumpharma.com/annual-reports?page=1#document-3331-0001213900-26-036504 <![CDATA[ 8-K/A - Current report ]]> https://ir.actiniumpharma.com/annual-reports?page=1#document-3325-0001213900-26-034807 Thu, 26 Mar 26 17:00:26 -0400 https://ir.actiniumpharma.com/annual-reports?page=1#document-3325-0001213900-26-034807 <![CDATA[ 8-K - Current report ]]> https://ir.actiniumpharma.com/annual-reports?page=1#document-3324-0001213900-26-016559 Fri, 13 Feb 26 17:01:17 -0500 https://ir.actiniumpharma.com/annual-reports?page=1#document-3324-0001213900-26-016559 <![CDATA[ 8-K - Current report ]]> https://ir.actiniumpharma.com/annual-reports?page=1#document-3323-0001213900-25-115586 Wed, 26 Nov 25 17:01:19 -0500 https://ir.actiniumpharma.com/annual-reports?page=1#document-3323-0001213900-25-115586 <![CDATA[ 10-Q - Quarterly report [Sections 13 or 15(d)] ]]> 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2, EX-99.1 ]]> https://ir.actiniumpharma.com/annual-reports?page=1#document-3322-0001213900-25-110979 Fri, 14 Nov 25 17:02:42 -0500 https://ir.actiniumpharma.com/annual-reports?page=1#document-3322-0001213900-25-110979 <![CDATA[ ARS - Annual Report to Security Holders ]]> https://ir.actiniumpharma.com/annual-reports?page=1#document-3316-0001213900-25-106708 Wed, 05 Nov 25 17:04:40 -0500 https://ir.actiniumpharma.com/annual-reports?page=1#document-3316-0001213900-25-106708 <![CDATA[ DEF 14A - Definitive proxy statements ]]> https://ir.actiniumpharma.com/annual-reports?page=1#document-3315-0001213900-25-106706 Wed, 05 Nov 25 17:03:09 -0500 https://ir.actiniumpharma.com/annual-reports?page=1#document-3315-0001213900-25-106706 <![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]> https://ir.actiniumpharma.com/annual-reports?page=1#document-3314-0001213900-25-079019 Wed, 20 Aug 25 17:01:10 -0400 https://ir.actiniumpharma.com/annual-reports?page=1#document-3314-0001213900-25-079019 <![CDATA[ 10-Q - Quarterly report [Sections 13 or 15(d)] ]]> 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2 ]]> https://ir.actiniumpharma.com/annual-reports?page=1#document-3313-0001213900-25-073743 Fri, 08 Aug 25 17:04:43 -0400 https://ir.actiniumpharma.com/annual-reports?page=1#document-3313-0001213900-25-073743 <![CDATA[ SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors ]]> https://ir.actiniumpharma.com/annual-reports?page=1#document-3308-0000932471-25-000841 Tue, 29 Jul 25 12:10:33 -0400 https://ir.actiniumpharma.com/annual-reports?page=1#document-3308-0000932471-25-000841 <![CDATA[ SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors ]]> SCHEDULE 13G/A, EX-24, EX-99 ]]> https://ir.actiniumpharma.com/annual-reports?page=2#document-3307-0002052113-25-002468 Wed, 16 Jul 25 19:04:09 -0400 https://ir.actiniumpharma.com/annual-reports?page=2#document-3307-0002052113-25-002468 <![CDATA[ 10-Q - Quarterly report [Sections 13 or 15(d)] ]]> 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2 ]]> https://ir.actiniumpharma.com/annual-reports?page=2#document-3304-0001213900-25-041614 Fri, 09 May 25 17:28:07 -0400 https://ir.actiniumpharma.com/annual-reports?page=2#document-3304-0001213900-25-041614 <![CDATA[ 8-K - Current report ]]> 8-K, EX-16.1 ]]> https://ir.actiniumpharma.com/annual-reports?page=2#document-3299-0001213900-25-041582 Fri, 09 May 25 17:00:38 -0400 https://ir.actiniumpharma.com/annual-reports?page=2#document-3299-0001213900-25-041582 <![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]> https://ir.actiniumpharma.com/annual-reports?page=2#document-3297-0001213900-25-028232 Wed, 02 Apr 25 18:23:14 -0400 https://ir.actiniumpharma.com/annual-reports?page=2#document-3297-0001213900-25-028232 <![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]> https://ir.actiniumpharma.com/annual-reports?page=2#document-3291-0001213900-25-028225 Wed, 02 Apr 25 18:20:53 -0400 https://ir.actiniumpharma.com/annual-reports?page=2#document-3291-0001213900-25-028225 <![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]> https://ir.actiniumpharma.com/annual-reports?page=2#document-3292-0001213900-25-028226 Wed, 02 Apr 25 18:21:19 -0400 https://ir.actiniumpharma.com/annual-reports?page=2#document-3292-0001213900-25-028226 <![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]> https://ir.actiniumpharma.com/annual-reports?page=2#document-3293-0001213900-25-028227 Wed, 02 Apr 25 18:21:56 -0400 https://ir.actiniumpharma.com/annual-reports?page=2#document-3293-0001213900-25-028227 <![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]> https://ir.actiniumpharma.com/annual-reports?page=2#document-3295-0001213900-25-028230 Wed, 02 Apr 25 18:22:36 -0400 https://ir.actiniumpharma.com/annual-reports?page=2#document-3295-0001213900-25-028230 <![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]> https://ir.actiniumpharma.com/annual-reports?page=2#document-3294-0001213900-25-028228 Wed, 02 Apr 25 18:22:17 -0400 https://ir.actiniumpharma.com/annual-reports?page=2#document-3294-0001213900-25-028228 <![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]> https://ir.actiniumpharma.com/annual-reports?page=2#document-3296-0001213900-25-028231 Wed, 02 Apr 25 18:22:55 -0400 https://ir.actiniumpharma.com/annual-reports?page=2#document-3296-0001213900-25-028231